Science Explorer Back to mapMap
Discussion
Researcher · University of Oxford · United Kingdom

Paul Klenerman

Paul Klenerman publishes mostly in Immunology, Infectious Diseases and Epidemiology, on topics such as Immune Cell Function and Interaction, Hepatitis C virus research and T-cell and B-cell Immunology.

ORCID 0000-0003-4307-9161 OpenAlex
World rank
#47,134
of 7,710,434 ranked researchers
Rank in United Kingdom
#3,798
of 367,258
Works
1,211
Citations
87k
Citations per work
72.1
h-index
140
i10-index 610Top 0.1% in Immunology
Paul Klenerman

What does Paul Klenerman research?

Paul Klenerman's work is mostly in Medicine (39%), Immunology and Microbiology (31%), Biochemistry, Genetics and Molecular Biology (4%).

Health Sciences: 470 works · 38.8% of their workMedicine: 470 works · 38.8% of their workInfectious Diseases: 176 works · 14.5% of their workEpidemiology: 166 works · 13.7% of their workHepatology: 128 works · 10.6% of their workLife Sciences: 424 works · 35.0% of their workImmunology and Microbiology: 372 works · 30.7% of their workImmunology: 317 works · 26.2% of their workVirology: 54 works · 4.5% of their workBiochemistry, Genetics and Molecular Biology: 52 works · 4.3% of their workMolecular Biology: 52 works · 4.3% of their workEverything else: 317 works · 26.2% of their workTHEIR WORKPaul Klenerman1,211works
Life Sciences35%Health Sciences39%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine47038.8%
    1. Immunology and Microbiology37230.7%
    2. Biochemistry, Genetics and Molecular Biology524.3%
  3. Everything else31726.2%
  1. 1Immunology26% of their works
  2. 2Infectious Diseases14% of their works
  3. 3Epidemiology14% of their works
  4. 4Hepatology11% of their works
  5. 5Virology4% of their works
  6. 6Molecular Biology4% of their works

Research topics

Which keywords describe Paul Klenerman's research?

The keywords of their largest research topics: Immune Response, Antiviral Therapy, Epidemiology, Liver Disease, Vaccine, ACE2 Receptor, SARS-CoV-2 and Natural Killer Cells.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 23 words, with their numbers
  1. Immune Response6414 topics
  2. Antiviral Therapy4633 topics
  3. Epidemiology3862 topics
  4. Liver Disease3712 topics
  5. Vaccine3182 topics
  6. ACE2 Receptor3122 topics
  7. SARS-CoV-23122 topics
  8. NK Cell Recognition2981 topic
  9. Natural Killer Cells2981 topic
  10. Hepatitis C Virus2541 topic
  11. Treatment2541 topic
  12. Foxp32031 topic
  13. TGF-ß2031 topic
  14. Coronavirus1801 topic
  15. spike protein1801 topic
  16. AIDS1381 topic
  17. HIV1381 topic
  18. Clinical Characteristics1321 topic
  19. Thrombosis1321 topic
  20. Chronic Hepatitis B1171 topic
  21. Hepatitis B Virus1171 topic
  22. Cytomegalovirus921 topic
  23. Infection921 topic

Where does Paul Klenerman work?

Paul Klenerman's main affiliation in the publication record is University of Oxford, United Kingdom.

How many publications and citations does Paul Klenerman have?

OpenAlex counts 1,211 works and 87,296 citations for Paul Klenerman, an h-index of 140, ranking #47,134 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Paul Klenerman. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.